ID   SCP2_RAT                Reviewed;         547 AA.
AC   P11915; Q63383; Q642G0;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 3.
DT   02-OCT-2024, entry version 180.
DE   RecName: Full=Sterol carrier protein 2 {ECO:0000305};
DE            Short=SCP-2;
DE   AltName: Full=Acetyl-CoA C-myristoyltransferase {ECO:0000303|PubMed:8063752, ECO:0000303|PubMed:9325339};
DE            EC=2.3.1.155 {ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339};
DE   AltName: Full=Non-specific lipid-transfer protein;
DE            Short=NSL-TP;
DE   AltName: Full=Propanoyl-CoA C-acyltransferase;
DE            EC=2.3.1.176 {ECO:0000269|PubMed:9245689, ECO:0000269|PubMed:9325339, ECO:0000269|PubMed:9553048};
DE   AltName: Full=SCP-2/3-oxoacyl-CoA thiolase {ECO:0000303|PubMed:8063752};
DE   AltName: Full=SCP-2/thiolase {ECO:0000303|PubMed:9325339};
DE            EC=2.3.1.16 {ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339};
DE   AltName: Full=SCP-chi;
DE   AltName: Full=Sterol carrier protein X;
DE            Short=SCP-X;
GN   Name=Scp2 {ECO:0000312|RGD:3642}; Synonyms=Scp-2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=1985920; DOI=10.1016/s0021-9258(18)52481-9;
RA   Seedorf U., Assmann G.;
RT   "Cloning, expression, and nucleotide sequence of rat liver sterol carrier
RT   protein 2 cDNAs.";
RL   J. Biol. Chem. 266:630-636(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2034675; DOI=10.1073/pnas.88.10.4338;
RA   Mori T., Tsukamoto T., Mori H., Tashiro Y., Fujiki Y.;
RT   "Molecular cloning and deduced amino acid sequence of nonspecific lipid
RT   transfer protein (sterol carrier protein 2) of rat liver: a higher
RT   molecular mass (60 kDa) protein contains the primary sequence of
RT   nonspecific lipid transfer protein as its C-terminal part.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:4338-4342(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1915369; DOI=10.1111/j.1432-1033.1991.tb16279.x;
RA   Ossendorp B.C., van Heusden G.P.H., de Beer A.L.J., Bos K., Schouten G.L.,
RA   Wirtz K.W.A.;
RT   "Identification of the cDNA clone which encodes the 58-kDa protein
RT   containing the amino acid sequence of rat liver non-specific lipid-transfer
RT   protein (sterol-carrier protein 2). Homology with rat peroxisomal and
RT   mitochondrial 3-oxoacyl-CoA thiolases.";
RL   Eur. J. Biochem. 201:233-239(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 33-547.
RC   TISSUE=Liver;
RX   PubMed=2334427; DOI=10.1016/0006-291x(90)92367-9;
RA   Ossendorp B.C., van Heusden G.P.H., Wirtz K.W.A.;
RT   "The amino acid sequence of rat liver non-specific lipid transfer protein
RT   (sterol carrier protein 2) is present in a high molecular weight protein:
RT   evidence from cDNA analysis.";
RL   Biochem. Biophys. Res. Commun. 168:631-636(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 275-547.
RC   STRAIN=CD Charles River; TISSUE=Liver;
RX   PubMed=2340090; DOI=10.1089/dna.1990.9.159;
RA   Billheimer J.T., Strehl L.L., Davis G.L., Strauss J.F. III, Davis L.G.;
RT   "Characterization of a cDNA encoding rat sterol carrier protein2.";
RL   DNA Cell Biol. 9:159-165(1990).
RN   [7]
RP   PROTEIN SEQUENCE OF 425-547.
RC   TISSUE=Liver;
RX   PubMed=3115977; DOI=10.1016/s0021-9258(18)45190-3;
RA   Pastuszyn A., Noland B.J., Bazan J.F., Fletterick R.J., Scallen T.J.;
RT   "Primary sequence and structural analysis of sterol carrier protein 2 from
RT   rat liver: homology with immunoglobulins.";
RL   J. Biol. Chem. 262:13219-13227(1987).
RN   [8]
RP   PROTEIN SEQUENCE OF 425-547.
RC   TISSUE=Liver;
RX   PubMed=3395344; DOI=10.1016/0006-291x(88)90711-5;
RA   Morris H.R., Larsen B.S., Billheimer J.T.;
RT   "A mass spectrometric study of the structure of sterol carrier protein SCP2
RT   from rat liver.";
RL   Biochem. Biophys. Res. Commun. 154:476-482(1988).
RN   [9]
RP   PROTEIN SEQUENCE OF 24-33; 354-363 AND 525-534, CATALYTIC ACTIVITY,
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=9325339; DOI=10.1074/jbc.272.41.26023;
RA   Antonenkov V.D., Van Veldhoven P.P., Waelkens E., Mannaerts G.P.;
RT   "Substrate specificities of 3-oxoacyl-CoA thiolase A and sterol carrier
RT   protein 2/3-oxoacyl-CoA thiolase purified from normal rat liver
RT   peroxisomes. Sterol carrier protein 2/3-oxoacyl-CoA thiolase is involved in
RT   the metabolism of 2-methyl-branched fatty acids and bile acid
RT   intermediates.";
RL   J. Biol. Chem. 272:26023-26031(1997).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=8063752; DOI=10.1016/s0021-9258(17)31960-9;
RA   Seedorf U., Brysch P., Engel T., Schrage K., Assmann G.;
RT   "Sterol carrier protein X is peroxisomal 3-oxoacyl coenzyme A thiolase with
RT   intrinsic sterol carrier and lipid transfer activity.";
RL   J. Biol. Chem. 269:21277-21283(1994).
RN   [11]
RP   FUNCTION (ISOFORM SCPX), AND CATALYTIC ACTIVITY.
RX   PubMed=9245689; DOI=10.1006/bbrc.1997.7007;
RA   Wanders R.J., Denis S., Wouters F., Wirtz K.W., Seedorf U.;
RT   "Sterol carrier protein X (SCPx) is a peroxisomal branched-chain beta-
RT   ketothiolase specifically reacting with 3-oxo-pristanoyl-CoA: a new, unique
RT   role for SCPx in branched-chain fatty acid metabolism in peroxisomes.";
RL   Biochem. Biophys. Res. Commun. 236:565-569(1997).
RN   [12]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=9553048; DOI=10.1101/gad.12.8.1189;
RA   Seedorf U., Raabe M., Ellinghaus P., Kannenberg F., Fobker M., Engel T.,
RA   Denis S., Wouters F., Wirtz K.W., Wanders R.J., Maeda N., Assmann G.;
RT   "Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice
RT   lacking the sterol carrier protein-2/sterol carrier protein-x gene
RT   function.";
RL   Genes Dev. 12:1189-1201(1998).
RN   [13]
RP   CATALYTIC ACTIVITY, FUNCTION (ISOFORM SCPX), AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=10706581;
RA   Ferdinandusse S., Denis S., van Berkel E., Dacremont G., Wanders R.J.;
RT   "Peroxisomal fatty acid oxidation disorders and 58 kDa sterol carrier
RT   protein X (SCPx). Activity measurements in liver and fibroblasts using a
RT   newly developed method.";
RL   J. Lipid Res. 41:336-342(2000).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-8 AND SER-537, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: [Isoform SCPx]: Plays a crucial role in the peroxisomal
CC       oxidation of branched-chain fatty acids (PubMed:8063752,
CC       PubMed:9325339). Catalyzes the last step of the peroxisomal beta-
CC       oxidation of branched chain fatty acids and the side chain of the bile
CC       acid intermediates di- and trihydroxycoprostanic acids (DHCA and THCA)
CC       (PubMed:8063752, PubMed:9325339). Also active with medium and long
CC       straight chain 3-oxoacyl-CoAs (PubMed:10706581, PubMed:9325339).
CC       Stimulates the microsomal conversion of 7-dehydrocholesterol to
CC       cholesterol and transfers phosphatidylcholine and 7-dehydrocholesterol
CC       between membrances, in vitro (PubMed:8063752). Isoforms SCP2 and SCPx
CC       cooperate in peroxisomal oxidation of certain naturally occurring
CC       tetramethyl-branched fatty acyl-CoAs (PubMed:9553048).
CC       {ECO:0000269|PubMed:10706581, ECO:0000269|PubMed:8063752,
CC       ECO:0000269|PubMed:9325339, ECO:0000269|PubMed:9553048}.
CC   -!- FUNCTION: [Isoform SCP2]: Mediates the transfer of all common
CC       phospholipids, cholesterol and gangliosides from the endoplasmic
CC       reticulum to the plasma membrane. May play a role in regulating
CC       steroidogenesis (By similarity). Stimulates the microsomal conversion
CC       of 7-dehydrocholesterol to cholesterol (PubMed:8063752). Also binds
CC       fatty acids and fatty acyl Coenzyme A (CoA) such as phytanoyl-CoA.
CC       Involved in the regulation phospholipid synthesis in endoplasmic
CC       reticulum enhancing the incorporation of exogenous fatty acid into
CC       glycerides. Seems to stimulate the rate-limiting step in phosphatidic
CC       acid formation mediated by GPAT3 (By similarity) (PubMed:9553048).
CC       Isoforms SCP2 and SCPx cooperate in peroxisomal oxidation of certain
CC       naturally occurring tetramethyl-branched fatty acyl-CoAs
CC       (PubMed:9553048). {ECO:0000250|UniProtKB:P22307,
CC       ECO:0000250|UniProtKB:P32020, ECO:0000269|PubMed:8063752,
CC       ECO:0000269|PubMed:9553048}.
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + an acyl-CoA = a 3-oxoacyl-CoA + CoA;
CC         Xref=Rhea:RHEA:21564, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:58342, ChEBI:CHEBI:90726; EC=2.3.1.16;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21566;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=choloyl-CoA + propanoyl-CoA = 3alpha,7alpha,12alpha-
CC         trihydroxy-24-oxo-5beta-cholestan-26-oyl-CoA + CoA;
CC         Xref=Rhea:RHEA:16865, ChEBI:CHEBI:57287, ChEBI:CHEBI:57373,
CC         ChEBI:CHEBI:57392, ChEBI:CHEBI:58507; EC=2.3.1.176;
CC         Evidence={ECO:0000269|PubMed:10706581, ECO:0000269|PubMed:9325339,
CC         ECO:0000269|PubMed:9553048};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:16867;
CC         Evidence={ECO:0000305|PubMed:10706581, ECO:0000305|PubMed:9325339,
CC         ECO:0000305|PubMed:9553048};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=4,8,12-trimethyltridecanoyl-CoA + propanoyl-CoA = 3-
CC         oxopristanoyl-CoA + CoA; Xref=Rhea:RHEA:10408, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57291, ChEBI:CHEBI:57351, ChEBI:CHEBI:57392;
CC         EC=2.3.1.176; Evidence={ECO:0000269|PubMed:9245689};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:10410;
CC         Evidence={ECO:0000305|PubMed:9245689};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + hexanoyl-CoA = 3-oxooctanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31203, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:62619, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31205;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + tetradecanoyl-CoA = 3-oxohexadecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:18161, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57349, ChEBI:CHEBI:57385; EC=2.3.1.155;
CC         Evidence={ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18163;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=3-oxohexadecanedioyl-CoA + CoA = acetyl-CoA +
CC         tetradecanedioyl-CoA; Xref=Rhea:RHEA:40343, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57288, ChEBI:CHEBI:77081, ChEBI:CHEBI:77084;
CC         Evidence={ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40344;
CC         Evidence={ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=propanoyl-CoA + tetradecanoyl-CoA = 3-oxo-2-
CC         methylhexadecanoyl-CoA + CoA; Xref=Rhea:RHEA:46344,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57385, ChEBI:CHEBI:57392,
CC         ChEBI:CHEBI:86042; Evidence={ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:46346;
CC         Evidence={ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + butanoyl-CoA = 3-oxohexanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31111, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57371, ChEBI:CHEBI:62418;
CC         Evidence={ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31113;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + octanoyl-CoA = 3-oxodecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31087, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57386, ChEBI:CHEBI:62548;
CC         Evidence={ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31089;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + decanoyl-CoA = 3-oxododecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31183, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:61430, ChEBI:CHEBI:62615;
CC         Evidence={ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31185;
CC         Evidence={ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + dodecanoyl-CoA = 3-oxotetradecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:31091, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:62543;
CC         Evidence={ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31093;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9325339};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=acetyl-CoA + hexadecanoyl-CoA = 3-oxooctadecanoyl-CoA + CoA;
CC         Xref=Rhea:RHEA:35279, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288,
CC         ChEBI:CHEBI:57379, ChEBI:CHEBI:71407;
CC         Evidence={ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9245689};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:35281;
CC         Evidence={ECO:0000305|PubMed:8063752, ECO:0000305|PubMed:9245689};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=3-oxo-(9Z-octadecenoyl)-CoA + CoA = (7Z)-hexadecenoyl-CoA +
CC         acetyl-CoA; Xref=Rhea:RHEA:47400, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57288, ChEBI:CHEBI:87695, ChEBI:CHEBI:87698;
CC         Evidence={ECO:0000269|PubMed:8063752};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47401;
CC         Evidence={ECO:0000305|PubMed:8063752};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCPx]:
CC       Reaction=7-dehydrocholesterol(in) = 7-dehydrocholesterol(out);
CC         Xref=Rhea:RHEA:62960, ChEBI:CHEBI:17759;
CC         Evidence={ECO:0000269|PubMed:8063752};
CC   -!- CATALYTIC ACTIVITY: [Isoform SCP2]:
CC       Reaction=7-dehydrocholesterol(in) = 7-dehydrocholesterol(out);
CC         Xref=Rhea:RHEA:62960, ChEBI:CHEBI:17759;
CC         Evidence={ECO:0000269|PubMed:8063752};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES: [Isoform SCPx]:
CC       Kinetic parameters:
CC         KM=4.6 uM for 3-oxooctanoyl-CoA {ECO:0000269|PubMed:9325339};
CC         KM=4 uM for 3-oxohexadecanoyl-CoA {ECO:0000269|PubMed:9325339};
CC         KM=2.9 uM for 3-oxohexadecanedioyl-CoA {ECO:0000269|PubMed:9325339};
CC         KM=3 uM for 3-oxo-2-methylpalmitoyl-CoA {ECO:0000269|PubMed:9325339};
CC         KM=2.8 uM for 24-oxo-THC-CoA {ECO:0000269|PubMed:9325339};
CC         KM=37.7 uM for CoA {ECO:0000269|PubMed:10706581};
CC         Vmax=78 umol/min/mg enzyme towards 3-oxooctanoyl-CoA
CC         {ECO:0000269|PubMed:9325339};
CC         Vmax=20.8 umol/min/mg enzyme towards 3-oxopalmitoyl-CoA
CC         {ECO:0000269|PubMed:9325339};
CC         Vmax=29.4 umol/min/mg enzyme towards 3-oxohexadecanedioyl-CoA
CC         {ECO:0000269|PubMed:9325339};
CC         Vmax=38 umol/min/mg enzyme towards 3-oxo-2-oxohexadecanoyl-CoA
CC         {ECO:0000269|PubMed:9325339};
CC         Vmax=9.6 umol/min/mg enzyme towards 24-oxo-THC-CoA
CC         {ECO:0000269|PubMed:9325339};
CC       pH dependence:
CC         Optimum pH is 7.6 with 3-oxooctanoyl-CoA and 3-oxo-2-methylpalmitoyl-
CC         CoA as substrates (PubMed:9325339). Optimum pH is 9.5 with
CC         3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestan-26-oyl-CoA as
CC         substrate (PubMed:10706581). {ECO:0000269|PubMed:10706581,
CC         ECO:0000269|PubMed:9325339};
CC   -!- SUBUNIT: [Isoform SCP2]: Interacts with PEX5; the interaction is
CC       essential for peroxisomal import. {ECO:0000250|UniProtKB:P22307}.
CC   -!- SUBCELLULAR LOCATION: [Isoform SCP2]: Peroxisome
CC       {ECO:0000250|UniProtKB:P32020}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P22307}. Mitochondrion
CC       {ECO:0000250|UniProtKB:P22307}.
CC   -!- SUBCELLULAR LOCATION: [Isoform SCPx]: Peroxisome
CC       {ECO:0000269|PubMed:8063752, ECO:0000269|PubMed:9325339}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=SCPx; Synonyms=SCP-2/thiolase {ECO:0000303|PubMed:9325339};
CC         IsoId=P11915-1; Sequence=Displayed;
CC       Name=SCP2;
CC         IsoId=P11915-2; Sequence=VSP_018897;
CC   -!- TISSUE SPECIFICITY: Liver > intestine > brain > lung, colon, stomach,
CC       spleen, kidney, heart and ovary.
CC   -!- TISSUE SPECIFICITY: [Isoform SCPx]: Expressed in liver (at protein
CC       level). {ECO:0000269|PubMed:8063752}.
CC   -!- TISSUE SPECIFICITY: [Isoform SCP2]: Expressed in liver (at protein
CC       level). {ECO:0000269|PubMed:8063752}.
CC   -!- PTM: [Isoform SCP2]: preSCP2, a protein with a molecular mass of about
CC       15 kDa, is processed into its mature form (SCP2) by proteolytic
CC       cleavage of a 20 residue leader sequence after translocation into
CC       peroxisomes. {ECO:0000250|UniProtKB:O62742}.
CC   -!- MISCELLANEOUS: [Isoform SCP2]: Contains a putative mitochondrial
CC       transit peptide at positions 1-20. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the thiolase-like
CC       superfamily. Thiolase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA40623.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA43060.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M62763; AAA40622.1; -; mRNA.
DR   EMBL; M62763; AAA40623.1; ALT_INIT; mRNA.
DR   EMBL; M57454; AAA42121.1; -; mRNA.
DR   EMBL; M57453; AAA42122.1; -; mRNA.
DR   EMBL; M58287; AAA41726.1; -; mRNA.
DR   EMBL; BC081713; AAH81713.1; -; mRNA.
DR   EMBL; M34728; AAA42120.1; -; mRNA.
DR   EMBL; X60654; CAA43060.1; ALT_INIT; mRNA.
DR   EMBL; X60654; CAA43061.1; -; mRNA.
DR   PIR; A39368; A39368.
DR   RefSeq; NP_612517.2; NM_138508.4.
DR   AlphaFoldDB; P11915; -.
DR   SMR; P11915; -.
DR   IntAct; P11915; 1.
DR   STRING; 10116.ENSRNOP00000015466; -.
DR   SwissLipids; SLP:000001233; -. [P11915-1]
DR   iPTMnet; P11915; -.
DR   PhosphoSitePlus; P11915; -.
DR   jPOST; P11915; -.
DR   PaxDb; 10116-ENSRNOP00000015420; -.
DR   GeneID; 25541; -.
DR   KEGG; rno:25541; -.
DR   UCSC; RGD:3642; rat. [P11915-1]
DR   AGR; RGD:3642; -.
DR   CTD; 6342; -.
DR   RGD; 3642; Scp2.
DR   eggNOG; KOG1406; Eukaryota.
DR   eggNOG; KOG4170; Eukaryota.
DR   InParanoid; P11915; -.
DR   OrthoDB; 1799125at2759; -.
DR   BioCyc; MetaCyc:MONOMER-14332; -.
DR   Reactome; R-RNO-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-RNO-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-RNO-389887; Beta-oxidation of pristanoyl-CoA.
DR   Reactome; R-RNO-9033241; Peroxisomal protein import.
DR   SABIO-RK; P11915; -.
DR   PRO; PR:P11915; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0003988; F:acetyl-CoA C-acyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0050633; F:acetyl-CoA C-myristoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0015485; F:cholesterol binding; ISO:RGD.
DR   GO; GO:0120020; F:cholesterol transfer activity; IDA:UniProtKB.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0036042; F:long-chain fatty acyl-CoA binding; ISO:RGD.
DR   GO; GO:0070538; F:oleic acid binding; ISO:RGD.
DR   GO; GO:0120019; F:phosphatidylcholine transfer activity; IDA:UniProtKB.
DR   GO; GO:1904121; F:phosphatidylethanolamine transfer activity; IDA:RGD.
DR   GO; GO:0033814; F:propanoyl-CoA C-acyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050632; F:propionyl-CoA C2-trimethyltridecanoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0008206; P:bile acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0071397; P:cellular response to cholesterol; IEP:RGD.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB.
DR   GO; GO:0032367; P:intracellular cholesterol transport; ISS:UniProtKB.
DR   GO; GO:1901373; P:lipid hydroperoxide transport; ISO:RGD.
DR   GO; GO:0015914; P:phospholipid transport; IBA:GO_Central.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:RGD.
DR   GO; GO:0045542; P:positive regulation of cholesterol biosynthetic process; IDA:RGD.
DR   GO; GO:1904109; P:positive regulation of cholesterol import; IDA:RGD.
DR   GO; GO:0032385; P:positive regulation of intracellular cholesterol transport; ISO:RGD.
DR   GO; GO:0010893; P:positive regulation of steroid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0071071; P:regulation of phospholipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0034699; P:response to luteinizing hormone; IEP:RGD.
DR   CDD; cd00826; nondecarbox_cond_enzymes; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   Gene3D; 3.30.1050.10; SCP2 sterol-binding domain; 1.
DR   InterPro; IPR003033; SCP2_sterol-bd_dom.
DR   InterPro; IPR036527; SCP2_sterol-bd_dom_sf.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR020615; Thiolase_acyl_enz_int_AS.
DR   InterPro; IPR020613; Thiolase_CS.
DR   InterPro; IPR020616; Thiolase_N.
DR   PANTHER; PTHR42870; ACETYL-COA C-ACETYLTRANSFERASE; 1.
DR   PANTHER; PTHR42870:SF1; NON-SPECIFIC LIPID-TRANSFER PROTEIN-LIKE 2; 1.
DR   Pfam; PF02036; SCP2; 1.
DR   Pfam; PF22691; Thiolase_C_1; 1.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   SUPFAM; SSF55718; SCP-like; 1.
DR   SUPFAM; SSF53901; Thiolase-like; 2.
DR   PROSITE; PS00098; THIOLASE_1; 1.
DR   PROSITE; PS00737; THIOLASE_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Alternative initiation; Cytoplasm;
KW   Direct protein sequencing; Lipid metabolism; Lipid transport;
KW   Lipid-binding; Mitochondrion; Peroxisome; Phosphoprotein;
KW   Reference proteome; Transferase; Transport.
FT   CHAIN           1..547
FT                   /note="Sterol carrier protein 2"
FT                   /id="PRO_0000034097"
FT   DOMAIN          433..543
FT                   /note="SCP2"
FT   MOTIF           545..547
FT                   /note="Microbody targeting signal"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         40
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         132
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         132
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         168
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         177
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         183
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22307"
FT   MOD_RES         183
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         211
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         282
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         341
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         341
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         432
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         432
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         438
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22307"
FT   MOD_RES         438
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         443
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         443
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         453
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         453
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         464
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         470
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P22307"
FT   MOD_RES         470
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         479
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         491
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         492
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         511
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         516
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         522
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         534
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   MOD_RES         537
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         544
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P32020"
FT   VAR_SEQ         1..404
FT                   /note="Missing (in isoform SCP2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_018897"
FT   CONFLICT        12
FT                   /note="P -> R (in Ref. 2; AAA40622/CAA43061 and 4;
FT                   AAH81713)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        50
FT                   /note="R -> A (in Ref. 2; AAA40622 and 4; AAH81713)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        265
FT                   /note="S -> T (in Ref. 1; AAA42122)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        427..428
FT                   /note="AG -> SV (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        436
FT                   /note="I -> V (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        446
FT                   /note="E -> D (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        450
FT                   /note="E -> Q (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        488
FT                   /note="D -> N (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        516
FT                   /note="S -> T (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        526
FT                   /note="A -> N (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        537
FT                   /note="S -> N (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        543
FT                   /note="D -> G (in Ref. 8; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   SITE            P11915-2:20..21
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:O62742"
SQ   SEQUENCE   547 AA;  58813 MW;  D0D1B435D2DC6AFB CRC64;
     MPSVALNSPR LPRVFVVGVG MTKFMKPGGE NSRDYPDLAK EAGQKALADR QIPYSAVEQA
     CVGYVYGEST CGQRAIYHSL GLTGIPIINV NNNCSTGSTA LFMAQQLVQG GLANCVLALG
     FEKMEKGSLG TKYSDRSNPL EKHIDVLINK YGMSACPFAP QLFGSAGKEH METYGTKVEH
     FAKIGWKNHK HSVNNPYSQF QDEYSLDEIM KSRPVFDFLT VLQCCPTSDG AAAAIVSSEE
     FVQKHGLQSK AVEIVAQEMV TDMPSTFEEK SVIKMVGYDM SKEAARKCYE KSGLGPSDVD
     VIELHDCFST NELLTYEALG LCPEGQGGAL VDRGDNTYGG KWVINPSGGL ISKGHPLGAT
     GLAQCAELCW QLRGEAGKRQ VPGAKVALQH NLGLGGAAVV TLYRMGFPEA ASSFRTHQIS
     AAPTSSAGDG FKANLIFKEI EKKLEEEGEE FVKKIGGIFA FKVKDGPGGK EATWVVDVKN
     GKGSVLPDSD KKADCTITMA DSDLLALMTG KMNPQSAFFQ GKLKIAGNMG LAMKLQSLQL
     QPDKAKL
//
